Invests in leading companies across pharmaceuticals, biopharmaceuticals, life science tools, diagnostics, medical technology, healthcare distribution, healthcare services, managed care, and selected consumer health. The focus is on businesses with strong market positions, diversified revenue streams, resilient demand, durable cash flows, solid balance sheets, and the capacity to create long-term value through innovation, scale, and disciplined capital allocation.
Updated 2026-03-23